159 related articles for article (PubMed ID: 2372538)
1. Novel substrates and inhibitors of peptidylglycine alpha-amidating monooxygenase.
Katopodis AG; May SW
Biochemistry; 1990 May; 29(19):4541-8. PubMed ID: 2372538
[TBL] [Abstract][Full Text] [Related]
2. A novel enzyme from bovine neurointermediate pituitary catalyzes dealkylation of alpha-hydroxyglycine derivatives, thereby functioning sequentially with peptidylglycine alpha-amidating monooxygenase in peptide amidation.
Katopodis AG; Ping D; May SW
Biochemistry; 1990 Jul; 29(26):6115-20. PubMed ID: 2207061
[TBL] [Abstract][Full Text] [Related]
3. Amidation of salicyluric acid and gentisuric acid: a possible role for peptidylglycine alpha-amidating monooxygenase in the metabolism of aspirin.
DeBlassio JL; deLong MA; Glufke U; Kulathila R; Merkler KA; Vederas JC; Merkler DJ
Arch Biochem Biophys; 2000 Nov; 383(1):46-55. PubMed ID: 11097175
[TBL] [Abstract][Full Text] [Related]
4. Reaction versus subsite stereospecificity of peptidylglycine alpha-monooxygenase and peptidylamidoglycolate lyase, the two enzymes involved in peptide amidation.
Ping D; Mounier CE; May SW
J Biol Chem; 1995 Dec; 270(49):29250-5. PubMed ID: 7493955
[TBL] [Abstract][Full Text] [Related]
5. pH-dependent stimulation of peptidylglycine alpha-amidating monooxygenase activity by a granule-associated factor.
Perkins SN; Husten EJ; Mains RE; Eipper BA
Endocrinology; 1990 Dec; 127(6):2771-8. PubMed ID: 2249628
[TBL] [Abstract][Full Text] [Related]
6. NN-dimethyl-1,4-phenylenediamine as an alternative reductant for peptidylglycine alpha-amidating mono-oxygenase catalysis.
Li C; Oldham CD; May SW
Biochem J; 1994 May; 300 ( Pt 1)(Pt 1):31-6. PubMed ID: 8198547
[TBL] [Abstract][Full Text] [Related]
7. Kinetic mechanism and intrinsic isotope effects for the peptidylglycine alpha-amidating enzyme reaction.
Francisco WA; Merkler DJ; Blackburn NJ; Klinman JP
Biochemistry; 1998 Jun; 37(22):8244-52. PubMed ID: 9609721
[TBL] [Abstract][Full Text] [Related]
8. Pyruvate-extended amino acid derivatives as highly potent inhibitors of carboxyl-terminal peptide amidation.
Mounier CE; Shi J; Sirimanne SR; Chen BH; Moore AB; Gill-Woznichak MM; Ping D; May SW
J Biol Chem; 1997 Feb; 272(8):5016-23. PubMed ID: 9030564
[TBL] [Abstract][Full Text] [Related]
9. Kinetic analyses of peptidylglycine alpha-amidating monooxygenase from pancreatic islets.
Noe BD; Katopodis AG; May SW
Gen Comp Endocrinol; 1991 Aug; 83(2):183-92. PubMed ID: 1916206
[TBL] [Abstract][Full Text] [Related]
10. The enzymatic formation of novel bile acid primary amides.
King L; Barnes S; Glufke U; Henz ME; Kirk M; Merkler KA; Vederas JC; Wilcox BJ; Merkler DJ
Arch Biochem Biophys; 2000 Feb; 374(2):107-17. PubMed ID: 10666288
[TBL] [Abstract][Full Text] [Related]
11. Kinetic and inhibition studies on substrate channelling in the bifunctional enzyme catalysing C-terminal amidation.
Moore AB; May SW
Biochem J; 1999 Jul; 341 ( Pt 1)(Pt 1):33-40. PubMed ID: 10377242
[TBL] [Abstract][Full Text] [Related]
12. Stable expression of full-length and truncated bovine peptidylglycine alpha-amidating monooxygenase complementary DNAs in cultured cells.
Perkins SN; Eipper BA; Mains RE
Mol Endocrinol; 1990 Jan; 4(1):132-9. PubMed ID: 2325663
[TBL] [Abstract][Full Text] [Related]
13. Inactivation of peptidylglycine α-hydroxylating monooxygenase by cinnamic acid analogs.
McIntyre NR; Lowe EW; Battistini MR; Leahy JW; Merkler DJ
J Enzyme Inhib Med Chem; 2016 Aug; 31(4):551-62. PubMed ID: 26024288
[TBL] [Abstract][Full Text] [Related]
14. 60 YEARS OF POMC: From POMC and α-MSH to PAM, molecular oxygen, copper, and vitamin C.
Kumar D; Mains RE; Eipper BA
J Mol Endocrinol; 2016 May; 56(4):T63-76. PubMed ID: 26667899
[TBL] [Abstract][Full Text] [Related]
15. Ubiquitin and ubiquitin-derived peptides as substrates for peptidylglycine alpha-amidating monooxygenase.
Chew GH; Galloway LC; McIntyre NR; Schroder LA; Richards KM; Miller SA; Wright DW; Merkler DJ
FEBS Lett; 2005 Aug; 579(21):4678-84. PubMed ID: 16098968
[TBL] [Abstract][Full Text] [Related]
16. Evidence for substrate preorganization in the peptidylglycine α-amidating monooxygenase reaction describing the contribution of ground state structure to hydrogen tunneling.
McIntyre NR; Lowe EW; Belof JL; Ivkovic M; Shafer J; Space B; Merkler DJ
J Am Chem Soc; 2010 Nov; 132(46):16393-402. PubMed ID: 21043511
[TBL] [Abstract][Full Text] [Related]
17. Glutathione, S-substituted glutathiones, and leukotriene C4 as substrates for peptidylglycine alpha-amidating monooxygenase.
Miller LA; Baumgart LE; Chew GH; deLong MA; Galloway LC; Jung KW; Merkler KA; Nagle AS; Poore DD; Yoon CH; Merkler DJ
Arch Biochem Biophys; 2003 Apr; 412(1):3-12. PubMed ID: 12646261
[TBL] [Abstract][Full Text] [Related]
18. Thiorphan, tiopronin, and related analogs as substrates and inhibitors of peptidylglycine alpha-amidating monooxygenase (PAM).
McIntyre NR; Lowe EW; Chew GH; Owen TC; Merkler DJ
FEBS Lett; 2006 Jan; 580(2):521-32. PubMed ID: 16405966
[TBL] [Abstract][Full Text] [Related]
19. Peptidylglycine-alpha-hydroxylating monooxygenase generates two hydroxylated products from its mechanism-based suicide substrate, 4-phenyl-3-butenoic acid.
Driscoll WJ; König S; Fales HM; Pannell LK; Eipper BA; Mueller GP
Biochemistry; 2000 Jul; 39(27):8007-16. PubMed ID: 10891082
[TBL] [Abstract][Full Text] [Related]
20. Peptidylglycine α-amidating monooxygenase as a therapeutic target or biomarker for human diseases.
Merkler DJ; Hawley AJ; Eipper BA; Mains RE
Br J Pharmacol; 2022 Jul; 179(13):3306-3324. PubMed ID: 35124797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
